IMAC Holdings Annual Meeting of Shareholders Reminder
IMAC Holdings Annual Meeting of Shareholders Reminder
Shareholders are reminded to vote their shares prior to the proxy voting deadline of 7:00pm on July 4, 2023
提醒股東在代理投票截止日期之前對股票進行投票 7晚上 00:00 2023 年 7 月 4 日
FRANKLIN, Tenn., June 28, 2023 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: BACK) ("IMAC"), a provider of innovative medical advancements and care specializing in regenerative rehabilitation orthopedic treatments without the use of surgery or opioids, reminds its shareholders that its Annual Meeting will be held July 5, 2023 at 11:00 am, local time, in Franklin, Tennessee.
田納西州富蘭克林，2023 年 6 月 28 日（GLOBE NEWSWIRE）— IMAC Holdings, Inc.（納斯達克股票代碼：BACK）（“IMAC”）是一家創新醫療進步和護理提供商，專門提供不使用手術或阿片類藥物的再生康復骨科治療。該公司提醒其股東，其年會將於當地時間2023年7月5日上午11點在田納西州富蘭克林舉行。
IMAC shareholders are encouraged to read the Proxy Statement filed in connection with the Meeting in detail and cast their votes prior to the proxy voting deadline.
鼓勵IMAC股東詳細閱讀與會議相關的委託書，並在代理投票截止日期之前投票。
IMAC's Board of Directors and management recommend that shareholders VOTE FOR all proposed resolutions.
IMAC的董事會和管理層建議股東對所有擬議決議投贊成票。
How do I vote?
我該如何投票？
If you are a stockholder of record, you may:
如果您是登記在冊的股東，您可以：
- Vote by internet. You will find the Control number and the internet address in your Notice of Internet Availability. Registered shareholders may be able to vote through their broker of record.
- Vote by email. Mark, date, sign the Proxy Card and send to proxy@equitystock.com.
- 通過互聯網投票。您將在互聯網可用性通知中找到控制號碼和互聯網地址。註冊股東可以通過其記錄在案的經紀人進行投票。
- 通過電子郵件投票。標記、註明日期、在代理卡上簽名然後發送至 proxy@equitystock.com。
About IMAC Holdings, Inc.
關於 IMAC Holdings, Inc.
IMAC Holdings owns and manages health and wellness centers that deliver sports medicine, orthopedic care, and restorative joint and tissue therapies for movement restricting pain and neurodegenerative diseases. IMAC is comprised of two business segments: outpatient medical centers and a clinical research division. With treatments to address both young and aging populations, IMAC Holdings owns or manages outpatient medical clinics that deliver regenerative rehabilitation services as a minimally invasive approach to acute and chronic musculoskeletal and neurological health problems. IMAC's research division is currently conducting a Phase I clinical trial evaluating a mesenchymal stem cell therapy candidate for bradykinesia due to Parkinson's disease. For more information visit .
IMAC Holdings擁有並管理健康和保健中心，這些中心提供運動醫學、骨科護理以及針對運動限制疼痛和神經退行性疾病的修復性關節和組織療法。IMAC由兩個業務部門組成：門診醫療中心和臨床研究部門。IMAC Holdings擁有或管理門診醫療診所，這些診所提供再生康復服務，作爲治療急性和慢性肌肉骨骼和神經系統健康問題的微創方法，提供針對年輕人和老齡化人羣的治療。IMAC的研究部門目前正在進行一項I期臨床試驗，評估帕金森氏病引起的運動遲緩的間充質幹細胞療法的候選藥物。欲瞭解更多信息，請訪問。
###
****
IMAC Investor Contact:
jeff@imacholdings.com
IMAC 投資者聯繫方式：
jeff@imacholdings.com
譯文內容由第三人軟體翻譯。